Over 150,000 Americans are diagnosed with colon cancer every year, making it one of the most common cancers. And it kills over 50,000 Americans each year, making it one of the deadliest.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Nearly one in eight men in the United States are diagnosed with prostate cancer in their lifetime. Every year, almost 300,000 discover that they have prostate cancer and over 30,000 die from it, making it one of the most survivable cancers and also the second highest cause of cancer death among men.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 30,000 Americans are living with amyotrophic lateral sclerosis (ALS).

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 2 million Americans are diagnosed with cancer each year.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 1.5 million Americans are living with blood cancers—leukemia, lymphoma, myeloma. Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

More than 1.5 million Americans live with lupus. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

More than 1 million Americans live with rheumatoid arthritis, a painful autoimmune disease that can damage joints, skin, eyes, lungs, and more. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

About 40,000 children and adults in the US and approximately a hundred thousand people worldwide live with cystic fibrosis or CF. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

About 20,000 American women are diagnosed with ovarian cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

Over 3 million Americans are diagnosed with skin cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

Nearly a million Americans are living with multiple sclerosis. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.

Nearly 1 million Americans and over 7 million people globally are living with Parkinson's disease. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.

The Massachusetts biotech industry leads the world in innovation and drug development. But its companies don’t have the support of its own leaders. Why?

Biomedical innovators are developing new autoimmune therapeutics - insurance reform will ensure new treatments and cures are accessible and affordable.

An independent and autonomous FDA is a key part of ensuring that the biotech innovation ecosystem can continue to thrive. As an agency, it is the gold standard globally for determining risk-reward benefit in therapies for patients, and the world looks to it to lead the way. The people at the FDA are trying hard to make sure that we actually make progress, and their work is a service to the American public.

America is the global leader in biomedical innovation because it has a market that values new medicines. When other countries pay less, they are free-riding on our willingness to pay for new treatments. Forcing drug manufacturers to charge the same price that these other countries mandate would backfire. Instead, policymakers should use trade negotiations to pressure other wealthy countries to pay their fair share.

Drug development is costly. Who takes the risk and funds the hope of new medicines? Investors do. How do they know which ones will work? They often don't.

At No Patient Left Behind, we believe for insurance to really be insurance it should fully cover the drugs your doctor prescribes when you’re sick–without high out-of-pocket costs.

Who creates new medicines? It takes teams of innovators working with the support of private funding to reach risky new summits and provide patients with new cures.